Yarrow Bioscience (YARW) Receivables (2017 - 2023)
Yarrow Bioscience's (YARW) quarterly Receivables came in at $250000.0 in Q3 2023, down 46.92% YoY from $471000.0 in Q3 2022, and up 6.84% on a QoQ basis from $234000.0 in Q2 2023.
Yarrow Bioscience (YARW) Receivables (2017 - 2023) Analysis & Trends
Yarrow Bioscience (YARW) has 7 years of Receivables data on file, last reported at $250000.0 in Q3 2023.
- Quarterly Receivables fell 46.92% year-over-year to $250000.0 in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $250000.0 (down 46.92% YoY) and the FY2022 annual result came in at $173000.0, down 98.68% from the prior year.
- Receivables rose to $250000.0 in Q3 2023, from $234000.0 in the prior quarter.
- In the past five years, Receivables ranged from a high of $21.6 million in Q4 2020 to a low of $105000.0 in Q1 2023.
- A 5-year average of $7.9 million and a median of $4.4 million in 2020 frame the typical range for Receivables.
- Annual changes were most pronounced in 2020 — Receivables surged 15914.07% — and 2022, when it plunged 98.68%.
- Tracing YARW's Receivables over 5 years: stood at $135000.0 in 2019, then surged by 15914.07% to $21.6 million in 2020, then slumped by 39.48% to $13.1 million in 2021, then sank by 98.68% to $173000.0 in 2022, then jumped by 44.51% to $250000.0 in 2023.
- The last three Receivables figures came in at $250000.0 (Q3 2023), $234000.0 (Q2 2023), and $105000.0 (Q1 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 2.13 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 6.57 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.93 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 160.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.06 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 912.74 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 215.33 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.09 Bn |
| 10 | Yarrow Bioscience | 32.54 Mn | 9.62 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 250,000.00 |
| Jun 30, 2023 | 234,000.00 |
| Mar 31, 2023 | 105,000.00 |
| Dec 31, 2022 | 173,000.00 |
| Sep 30, 2022 | 471,000.00 |
| Jun 30, 2022 | 304,000.00 |
| Mar 31, 2022 | 535,000.00 |
| Dec 31, 2021 | 13.08 Mn |
| Sep 30, 2021 | 17.38 Mn |
| Jun 30, 2021 | 18.47 Mn |
| Mar 31, 2021 | 18.86 Mn |
| Dec 31, 2020 | 21.62 Mn |
| Sep 30, 2020 | 16.79 Mn |
| Jun 30, 2020 | 10.41 Mn |
| Mar 31, 2020 | 8.33 Mn |
| Dec 31, 2019 | 135,000.00 |
| Jun 30, 2018 | 93,000.00 |
| Mar 31, 2018 | 234,000.00 |
| Dec 31, 2017 | 786,000.00 |